# EDGAR Filing Document

**Accession Number:** 0002119432
**File Stem:** 0001753926-26-001040
**Filing Date:** 2026-6
**Character Count:** 11265
**Document Hash:** 52caaa31b17ce3a4b5995371b1c98402
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001753926-26-001040.hdr.sgml**: 20260623

**ACCESSION NUMBER**: 0001753926-26-001040

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260618

**FILED AS OF DATE**: 20260623

**DATE AS OF CHANGE**: 20260623

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Taylor Mark Andrew
- **CENTRAL INDEX KEY:** 0002119432

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41245
- **FILM NUMBER:** 261112549

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 418 SPEARGRASS FLAT ROAD
- **CITY:** QUEENSTOWN
- **PROVINCE COUNTRY:** Q2
- **ZIP:** 00000
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Prospect Finance Ltd
- **CENTRAL INDEX KEY:** 0002120961

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** Q2
- **FISCAL YEAR END:** 1231
- **LEGAL ENTITY IDENTIFIER:** 9845001F5FA855EZ4753

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41245
- **FILM NUMBER:** 261112547

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** LEVEL 4 16 VIADUCT HARBOUR AVENUE
- **CITY:** AUCKLAND
- **PROVINCE COUNTRY:** Q2
- **ZIP:** 00000
- **BUSINESS PHONE:** 64-21-782-797

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** LEVEL 4 16 VIADUCT HARBOUR AVENUE
- **CITY:** AUCKLAND
- **PROVINCE COUNTRY:** Q2
- **ZIP:** 00000
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Prospect Capital Securities Ltd
- **CENTRAL INDEX KEY:** 0002120744

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** Q2
- **FISCAL YEAR END:** 1231
- **LEGAL ENTITY IDENTIFIER:** 9845008952CE894DA749

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41245
- **FILM NUMBER:** 261112548

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** LEVEL 4 16 VIADUCT HARBOUR AVENUE
- **CITY:** AUCKLAND
- **PROVINCE COUNTRY:** Q2
- **ZIP:** 00000
- **BUSINESS PHONE:** 64-21-782-797

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** LEVEL 4 16 VIADUCT HARBOUR AVENUE
- **CITY:** AUCKLAND
- **PROVINCE COUNTRY:** Q2
- **ZIP:** 00000
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CDT Equity Inc.
- **CENTRAL INDEX KEY:** 0001896212
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 873272543
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 4851 TAMIAMI TRAIL NORTH
- **STREET 2:** SUITE 200
- **CITY:** NAPLES
- **STATE:** FL
- **ZIP:** 34103
- **BUSINESS PHONE:** (646) 491 9132

**MAIL ADDRESS:**
- **STREET 1:** 4851 TAMIAMI TRAIL NORTH
- **STREET 2:** SUITE 200
- **CITY:** NAPLES
- **STATE:** FL
- **ZIP:** 34103

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CONDUIT PHARMACEUTICALS INC.
- **DATE OF NAME CHANGE:** 20230922

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Murphy Canyon Acquisition Corp.
- **DATE OF NAME CHANGE:** 20211130

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[x] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Taylor Mark Andrew<br><sub>(Last) (First) (Middle)</sub><br>418 SPEARGRASS FLAT ROAD<br><sub>(Street)</sub><br>QUEENSTOWN, NEW ZEALAND 00000<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-06-18 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>CDT Equity Inc. [ CDT ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Prospect Capital Securities Ltd<br><sub>(Last) (First) (Middle)</sub><br>LEVEL 4 16 VIADUCT HARBOUR AVENUE<br><sub>(Street)</sub><br>AUCKLAND, NEW ZEALAND 00000<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-06-18 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>CDT Equity Inc. [ CDT ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Prospect Finance Ltd<br><sub>(Last) (First) (Middle)</sub><br>LEVEL 4 16 VIADUCT HARBOUR AVENUE<br><sub>(Street)</sub><br>AUCKLAND, NEW ZEALAND 00000<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-06-18 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>CDT Equity Inc. [ CDT ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-06-18 |  | S | V | 5000<sup>(1)</sup> | D | 0.7052<sup>(2)</sup> | 1464711 | I | By Prospect Capital Securities Limited<sup>(3)</sup> |
| Common Stock | 2026-06-18 |  | S | V | 1464711<sup>(1)</sup> | D | 1.44<sup>(2)</sup> | 0 | I | By Prospect Capital Securities Limited<sup>(3)</sup> |
| Common Stock | 2026-06-18 |  | S | V | 5000<sup>(1)</sup> | D | 0.751<sup>(4)</sup> | 593289 | I | By Prospect Finance Limited<sup>(3)</sup> |
| Common Stock | 2026-06-18 |  | S | V | 593289<sup>(1)</sup> | D | 1.3975<sup>(4)(5)</sup> | 0 | I | By Prospect Finance Limited<sup>(3)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Number of shares of common stock, par value $0.0001 per share ("Common Stock"), of CDT Equity Inc. (the "Issuer") reported gives effect to the 1-for-25 reverse split of the Common Stock effected by the Company as of the opening of market on March 26, 2026.

(2) On June 18, 2026, Prospect Capital Securities Limited, a New Zealand company ("Prospect Capital") sold 5,000 shares of Common Stock in the open market at a sales price per share of $0.7052 and 1,464,711 shares of Common Stock in the open market at a sales price per share of $1.44.

(3) Mark Taylor is the sole director and sole shareholder of each of Prospect Capital and Prospect Finance Limited, a New Zealand company ("Prospect Finance"). By virtue of these relationships, Mr. Taylor may be deemed to beneficially own the securities held of record by each of Prospect Capital and Prospect Finance. Mr. Taylor disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.

(4) On June 18, 2026, Prospect Finance sold 5,000 shares of Common Stock in the open market at a sales price per share of $0.751 and 593,289 shares of Common Stock in the open market at prices ranging from $1.25 to $1.67 per share, inclusive.

(5) The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock sold at each separate price within such range.

**Signature:** /s/ Mark Taylor  
**Date:** 2026-06-23

**Signature:** Prospect Capital Securities Ltd, by /s/ Mark Taylor  
**Date:** 2026-06-23

**Signature:** Prospect Finance Ltd, by /s/ Mark Taylor, Director  
**Date:** 2026-06-23

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**